Transgenics go commercial

被引：0
|
作者：
Young, MW
Tiedemann, G
Pepin, RA
Turner, JD
Okita, WB
Harvey, M
Groet, S
Curling, JM
机构：
[1] Genzyme Corp, Commercial Dev, Framingham, MA 01701 USA
[2] Genzyme Corp, Technol Dev, Framingham, MA 01701 USA
[3] Genzyme Corp, Business Dev, Framingham, MA 01701 USA
[4] Fresenius AG, Business Dev & Acquisit, Homburg, Germany
[5] Bristol Myers Squibb Co, External Sci & Technol, New York, NY 10154 USA
[6] Nexia Biotechnol Inc, St Anne De Bellevue, PQ, Canada
来源：
BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT | 1998年 / 11卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Critical issues surround the adoption of transgenic technology as it is applied to biotherapeutic protein expression in milk. Several scale-up factors make pharmaceutical production in herds of transgenic dairy livestock an attractive alternative to mammalian cell culture.
引用
收藏
页码：24 / +
相关论文
共 50 条
12345